15 Panel Dip Card
The 15 panel dip card is a fast, reliable, and easy-to-use urine screening device designed to
detect ten commonly abused drugs in a single test format. This multi-drug detection dip card
is widely used in workplaces, rehabilitation programs, probation monitoring, healthcare screening,
law enforcement, and personal testing where accurate and efficient drug screening is required.
Showing the single result
Dip card 15 Panel Detects GAB, ETG, FEN & K2, As low as $0.97 per test
AMP, BAR, BUP, BZO, COC, EtG, FEN, K2, MDMA, MET, MTD, OPI/MOR, OXY, PCP, GABAForensic UseAs low As$0.97 $0.97 - $1.21
Bulk Pricing that Cuts the Budget in Half
Priority Shipping For Bulk Orders.
Dedicated Wholesale Representative.
Quality That Is Reliable For the Nation.
Key Features of 15 Panel Dip Card
The Serenity 15 Panel Multi-Level Dip Card detects 15 substances including four that no standard 12 panel screen can detect: Gabapentin, EtG (alcohol metabolite), Fentanyl, and K2 Synthetic Cannabinoids. Forensic Use Only. As low as $0.97 per card in bulk — the most cost-effective multi-specialty dip card in the range. Results in 5 minutes. Same-day shipping.
- Rapid results – preliminary screening complete in 5 to 10 minutes for 6 types of drugs and variants
- Fully observed collection – tamper-resistant process with no restroom needed
- On-site ready – no lab, no special equipment, no collection facility required
- Detects recent use – identifies drug use within the past 24 to 48 hours
- Minimal training required – straightforward administration for any staff member
- Individually sealed sterile devices – hygienic single-use packaging for every test
15 Panel Multi Dip Card Test specifications
| Code | Full Substance Name | Cutoff | What It Catches |
|---|---|---|---|
| AMP | Amphetamines | 1000 ng/mL | Adderall, Vyvanse, prescription and illicit amphetamines |
| BAR | Barbiturates | 300 ng/mL | Phenobarbital, butalbital, secobarbital — sedative class distinct from BZO |
| BUP | Buprenorphine | 10 ng/mL | Suboxone, Subutex — detects MAT compliance at therapeutic concentrations a standard OPI strip misses |
| BZO | Benzodiazepines | 300 ng/mL | Xanax, Valium, Klonopin, Ativan — full benzodiazepine class |
| COC | Cocaine | 300 ng/mL | Cocaine and crack cocaine — detects urinary metabolite benzoylecgonine |
| EtG | Ethyl Glucuronide (Alcohol Metabolite) | 300 ng/mL | Alcohol consumption up to 80 hours post-use — not detectable on any standard drug panel |
| FEN | Fentanyl | 20 ng/mL | Illicit fentanyl and primary fentanyl analogs — added to SAMHSA federal panels July 2025. Not triggered by standard OPI panels |
| GABA | Gabapentin (GABA) | 1000 ng/mL | Neurontin, pregabalin — widely misused prescription anticonvulsant documented in opioid-adjacent populations. Not detected on any standard panel |
| K2 | Synthetic Cannabinoids (K2/Spice) | 50 ng/mL | K2, Spice, synthetic marijuana — does not cross-react with THC. Requires its own dedicated antibody panel |
| MDMA | Methylenedioxymethamphetamine | 500 ng/mL | Ecstasy, Molly — independent dedicated panel; may not appear reliably on AMP strip at recreational concentrations |
| MET | Methamphetamine | 1000 ng/mL | Crystal meth, street methamphetamine — dedicated panel independent of AMP |
| MTD | Methadone | 300 ng/mL | Methadone maintenance — does not appear on standard OPI strip |
| OPI/MOR | Opiates / Morphine | 300 ng/mL | Heroin, codeine, morphine |
| OXY | Oxycodone | 100 ng/mL | OxyContin, Percocet — does not appear on standard OPI strip |
| PCP | Phencyclidine | 25 ng/mL | PCP (angel dust) — dissociative hallucinogen |
Red codes are the four specialty panels not present on any standard 12 panel configuration: EtG, FEN, GABA, and K2. Note: this card does not include THC — the THC panel position is replaced by GABA and K2 within the 15-substance count. Requires a separate urine specimen collection container. Results in 5 minutes.
| Product | All 15 Panels | Classification | As Low As |
|---|---|---|---|
| Dip Card 15 Panel — GAB, EtG, FEN and K2 SKU: SM-DOA-6155FUO |
AMP | BAR | BUP | BZO | COC EtG/300ng | FEN/20ng | GABA/1000ng | K2/50ng MDMA | MET | MTD | OPI/MOR | OXY | PCP |
Forensic Use Only | $0.97 |
Forensic Use Only. All presumptive positive results require GC-MS or LC-MS/MS confirmation before formal action. Requires separate urine collection container. Results in 5 minutes. For bulk pricing call 561-897-9238 or email [email protected].
Easy Steps To Use The 15 Panel Dip Card
Step 1 — Collect
Remove the drug test cup from its sealed pouch and use it as soon as possible. Have the subject provide a urine sample directly into the cup, filling to the indicated line.
Step 2 — Dip & Wait
At 2–4 minutes, verify the temperature of the specimen using the built-in temperature strip. A green indicator confirms the sample is valid and within the acceptable range of 90–100°F.
Step 3 — Read
Peel back the label when ready to interpret results. Read results within 5 minutes of collection. Do not read results after 8 minutes, as the extended window may affect accuracy.
Positive
Two colored bands appear — one in the control region (C) and one in the test region (T). This indicates no drug was detected above the cutoff level.
Negative
Two colored bands appear, one in the control region (C) and another in the test region (T) for the drug in question.
Invalid
The control band fails to appear entirely. Discard the test and retest with a fresh cup within 3 minutes. If the problem persists, contact your distributor.
What is Included in a 15 Panel Dip Card?
The 15 panel dip card (SM-DOA-6155FUO) from 12 Panel Now is a single Serenity Multi-Level Dip Card engineered specifically around four detection gaps that no standard 12 panel configuration addresses: Gabapentin (GABA) at 1000 ng/mL, Ethyl Glucuronide (EtG) at 300 ng/mL, Fentanyl (FEN) at 20 ng/mL, and K2 Synthetic Cannabinoids at 50 ng/mL. These four specialty panels are added to an 11-substance professional baseline — AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI/MOR, OXY, PCP — to reach 15 total panels. Note that THC is not included in this configuration, with that panel position used to accommodate a fifth standard substance (PCP is retained) within the 15-substance count.
At $0.97 per card in bulk, the 15 panel card delivers more specialty panels per dollar than any other configuration in the 12 Panel Now dip card range. A program running a standard 12 panel card and adding a separate GABA strip, EtG strip, FEN strip, and K2 strip would spend approximately $1.65 to $2.00 per collection event in total. The 15 panel card consolidates all four into one card at $0.97.
The four specialty panels — and why each one requires a dedicated antibody that no standard panel provides:
GABA / Gabapentin at 1000 ng/mL — The Only Point-of-Care Multi-Panel Screen That Catches Neurontin
Gabapentin (Neurontin, 300 to 800 mg tablets) is a prescription anticonvulsant prescribed for nerve pain, epilepsy, and restless leg syndrome. It is widely misused in opioid-adjacent populations because it potentiates opioid effects, produces euphoria and sedation at high doses, and is accessible by prescription or illicit purchase. It does not trigger any standard drug panel antibody at any count because gabapentin's molecular structure is entirely distinct from every substance class covered by immunoassay panels. A patient taking 3600 mg of gabapentin daily returns a completely negative result on a 28-panel cup. The dedicated GABA panel at 1000 ng/mL on the 15 panel card is the only available point-of-care multi-panel detection method for this substance.
EtG / Ethyl Glucuronide at 300 ng/mL — 80-Hour Alcohol Detection Across the Weekly Inter-Test Window
EtG is the primary urinary metabolite of ethanol, formed by liver conjugation after alcohol consumption. Unlike direct alcohol urine tests, EtG remains detectable for 24 to 80 hours after consumption depending on the volume consumed and individual metabolism. For programs conducting weekly urine collections, EtG at 300 ng/mL covers approximately 70% of the 168-hour inter-test interval — the alcohol abstinence monitoring window where breathalyzers and direct alcohol tests cannot reach. Per SAMHSA MAT guidelines, concurrent alcohol monitoring alongside substance screening is a documented compliance requirement.
FEN / Fentanyl at 20 ng/mL — Federal Mandate Compliance in the Same Card
Fentanyl is approximately 50 to 100 times more potent than morphine per NIDA fentanyl research, meaning illicit use occurs at concentrations far below what would trigger a standard OPI antibody calibrated to morphine. Fentanyl does not cross-react with the OPI/MOR panel at any clinically relevant concentration. The dedicated FEN panel at 20 ng/mL provides point-of-care detection within the 12 to 48 hour post-use window. Added to SAMHSA Mandatory Guidelines for Federal Workplace Drug Testing effective July 2025.
K2 / Synthetic Cannabinoids at 50 ng/mL — Spice Detection That Every THC Panel Misses
Synthetic cannabinoids marketed as K2, Spice, or synthetic marijuana are chemically distinct from delta-9-THC. They bind to the same cannabinoid receptors but their molecular structures are entirely different from THC, meaning no THC antibody at any cutoff level will detect them. A specimen from a person who used K2 within the detection window returns a completely negative THC result on any standard drug test. The dedicated K2 panel at 50 ng/mL detects synthetic cannabinoid metabolites using a K2-specific antibody. Per NIDA synthetic cannabinoid research, K2/Spice is significantly documented in correctional and residential recovery populations.
The 15 Panel Card in Context: What It Covers and What It Does Not
The 15 panel card covers AMP, BAR, BUP, BZO, COC, EtG, FEN, GABA, K2, MDMA, MET, MTD, OPI/MOR, OXY, and PCP. It does not include THC. Programs that require cannabis screening alongside these 15 substances should consider the 16 panel dip card, which includes THC alongside EtG, FEN, and Kratom. Programs that require only a subset of the four specialty panels should compare the 14 panel dip card range, where the $1.39 cards include EtG and FEN alongside specific combinations of KRA, K2, PCP, BAR, and ADLTX.
15 Panel Dip Card Features The Highest Specialty Coverage
15 Panel Drug Test Dip Card from 12 Panel Now: Gabapentin, EtG, Fentanyl and K2 Alongside the Full Professional Baseline — $0.97 Per Card in Bulk: The 15 panel dip card closes four specific detection gaps that no standard 12 panel screen addresses — Gabapentin, EtG, Fentanyl, and K2 — in a single Forensic Use Only card at $0.97 per card in bulk. The most cost-effective specialty-panel dip card in the 12 Panel Now range.
- GABA at 1000ng/mL: The Most Significant Undetected Substance in Opioid-Adjacent Populations — Now in a Multi-Panel Card: Gabapentin misuse is documented across MAT, treatment, correctional, and pain management populations. Per NIDA prescription drug misuse data, gabapentin is increasingly documented as a substance used to potentiate opioid effects and manage withdrawal. No standard drug panel detects it. The dedicated GABA panel at 1000 ng/mL on the 15 panel card provides the only available point-of-care multi-panel screening solution for gabapentin alongside a comprehensive substance baseline.
- K2 at 50ng/mL: Synthetic Cannabinoid Detection That Every THC Panel Misses: K2 compounds return a negative result on every THC panel at every cutoff because K2 and THC are chemically distinct substances. The dedicated K2 panel at 50 ng/mL uses a synthetic cannabinoid-specific antibody to detect K2/Spice metabolites in urine for 24 to 72 hours after use. For correctional programs, residential recovery facilities, and community supervision programs where K2 use is documented, the 15 panel card provides the only available single-card multi-panel detection.
- EtG at 300ng/mL: 80-Hour Alcohol Monitoring Over the Full Weekly Collection Interval: EtG detects the alcohol metabolite Ethyl Glucuronide for up to 80 hours post-consumption, covering approximately 70% of the standard 168-hour weekly inter-test interval. For programs running weekly urine collections, this provides meaningful alcohol abstinence documentation where breathalyzers and direct alcohol tests have no reach. Standard drug tests at any panel count do not include an EtG panel.
- FEN at 20ng/mL: Federal Workplace Mandate Compliance Included as Standard: Fentanyl at 20 ng/mL is included as a standard panel per the July 2025 SAMHSA Mandatory Guidelines update for federal workplace drug testing. The FEN panel detects illicit fentanyl and primary fentanyl analogs in the 12 to 48 hour post-use window using a dedicated fentanyl antibody that standard OPI strips will not trigger.
- Complete Professional Baseline: BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI/MOR, OXY, PCP and AMP All Standard: The 11-substance professional baseline covers every standard substance class: stimulants (AMP, MET, MDMA), the full opioid class (BUP/10ng, MTD, OPI/MOR/300ng, OXY/100ng), sedatives (BAR, BZO), cocaine, and PCP. BUP at 10 ng/mL catches Suboxone compliance that a standard OPI strip misses. OXY at 100 ng/mL catches Percocet that a standard OPI strip misses. All 11 baseline panels are standard on this card alongside the four specialty additions.
- $0.97 Per Card in Bulk: The Most Specialty Coverage Per Dollar in the Dip Card Range: Four specialty panels (GABA, EtG, FEN, K2) alongside an 11-substance professional baseline for $0.97 per card in bulk. At this price point, adding all four specialty panels to a standard collection event costs $0.97 total — less than running two separate single-panel add-on strips. For programs currently using a 12 panel card plus separate GABA, EtG, FEN, and K2 strips, the 15 panel card consolidates the entire test into a single dip at a fraction of the combined cost.
Contact for Bulk 15 Panel Dip Card Orders, Wholesale Pricing and Private Label: 561-897-9238 | [email protected]
Check other product variations
for Multi Dip Cards
From everyday staples to specialty products:
- Multi Strips
- 5 Panel Dip Cards
- 10 Panel Dip Cards
- 12 Panel Dip Cards
- 14 Panel Dip Cards
- 19 Panel Dip Cards
10 Panel Dip
13 Dip Panel
12 Panel Dip
Dip Cards
Wholesale and Private Label 15 Panel Dip Cards: Bulk Pricing from $0.97, OEM and Custom Branding Available
12 Panel Now offers the 15 Panel Dip Card (SM-DOA-6155FUO) at bulk wholesale pricing starting at $0.97 per card. Tiered volume pricing is available at every order level — the more you order, the lower your per-card cost. All orders placed before 3:00 PM EST ship the same day. Free shipping is available on qualifying bulk purchases.
For organizations purchasing at volume, 12 Panel Now offers a guaranteed 10% price beat on any current supplier's documented pricing for the same product. Send your current supplier's quote directly to [email protected] and we will match and beat it before your next order. All wholesale accounts receive dedicated account management and priority same-day shipping on standing orders.
The 15 panel card is in continuous stock with no backorders. Order in any quantity — from a single case to container-direct volume — and receive the same industry-leading per-card price with the same same-day shipping guarantee. For current volume pricing at your specific order size, call 561-897-9238 or email [email protected].
OEM and Private Label — 15 Panel Dip Card
12 Panel Now manufactures the Serenity 15 Panel Dip Card and offers full OEM and private label programs for distributors, healthcare organizations, treatment networks, court supply organizations, and drug testing companies that need a professionally branded 15 panel specialty dip card product.
Private label options include:
- Custom foil pouch branding with your organization's logo and color scheme
- Custom card face printing with your brand name and panel labeling
- Custom outer box and retail packaging for resale programs
- White-label configurations for distributor resale networks
- OEM manufacturing to custom panel specifications for organizations requiring modifications to the standard 15 panel configuration
The 15 panel format covering Gabapentin, EtG, Fentanyl, and K2 alongside the full professional baseline — represents a specialty product that is not widely available from other manufacturers at this price point. Private label programs allow distributors and large-volume buyers to bring this product to their own client base under their own branding at the most competitive per-card manufacturing price available. Minimum order quantities and setup timelines are available on request.
For wholesale accounts, private label setup, OEM specifications, and distributor pricing contact:
12 Panel Now — Wholesale and Private Label
801 N Congress Ave, Boynton Beach FL 33426
561-897-9238 | [email protected]
12panelnow.com/wholesale | 12panelnow.com/private-label
What 12 Panel Now Offers:
220,000 Sq. Ft. Mega
Warehouse
We operate one of the largest drug-testing fulfillment centers in the country, stocked and ready to ship every day.
Lowest Wholesale Pricing. Highest Commissions. Period.
We aggressively price our products so you win more deals, while paying industry-leading commissions to our partners.
Same-Day Blind Drop Shipping
We ship directly to your customers — no branding, no invoices, no paper trail back to us. You keep the relationship. We do the heavy lifting.
Private Label Available
Want your own brand on the box? We’ve got you covered.
Build equity while selling proven products.
Real-Time Partner Portal
Track every order, commission, and customer in one clean dashboard. No guessing. No spreadsheets. Total transparency.
Where the 15 Panel Dip Card Is Used: Settings, Applications and Why This Specific Configuration
| Setting | Primary Applications | Why the 15 Panel Dip Card |
| Correctional Facilities | Institutional drug screening covering K2 synthetic cannabinoid contraband, Gabapentin diversion, Fentanyl supply contamination detection, and alcohol monitoring — all via a single $0.97 card alongside the full stimulant and opioid baseline | K2 and Gabapentin are among the most significant undetected contraband substances in US correctional facilities. Both can be mailed in legal packaging, both pass every standard cup screen, and both are documented institutional substance concerns. Fentanyl is confirmed in drug supply in all 50 US states per CDC overdose data. The 15 panel card closes all four gaps simultaneously for $0.97 per collection event — no separate strips, no additional workflow steps. |
| MAT and Addiction Treatment Programs | Gabapentin misuse monitoring in opioid treatment populations, K2 detection for residential patients using synthetic cannabinoids, EtG alcohol abstinence monitoring over the inter-test interval, FEN for fentanyl concurrent use alongside BUP and MTD compliance | MAT programs deal with polydrug-using populations where Gabapentin is documented as an opioid potentiator and K2 is used as a legal substance workaround that passes standard screens. BUP at 10 ng/mL and MTD at 300 ng/mL provide complete MAT compliance monitoring alongside GABA and K2 detection. Per SAMHSA MAT guidelines, comprehensive concurrent substance and alcohol monitoring is required. All four specialty needs addressed in a single $0.97 card. |
| Pain Management Clinics | Gabapentin co-prescription compliance monitoring alongside opioid compliance (BUP, OXY, OPI/MOR), Fentanyl adherence and diversion screening, comprehensive concurrent substance baseline for patients on complex medication regimens | Pain management patients are frequently co-prescribed Gabapentin (Neurontin or pregabalin) alongside opioid analgesics. The GABA panel at 1000 ng/mL enables compliance verification that no standard cup panel provides — confirming the patient is taking their Gabapentin prescription rather than diverting it. OXY at 100 ng/mL, BUP at 10 ng/mL, and OPI/MOR at 300 ng/mL provide full prescription opioid compliance coverage. FEN at 20 ng/mL covers transdermal fentanyl adherence and potential illicit supplemental use. |
| Sober Living and Residential Programs | Weekly resident accountability screening with 80-hour alcohol detection via EtG, K2 synthetic cannabinoid detection for facilities where Spice is documented, Fentanyl supply detection, Gabapentin monitoring for residents using it as a self-managed opioid substitute | Sober living facilities running weekly urine collections need EtG at 300 ng/mL to cover the full inter-test alcohol abstinence window. K2 is documented in residential recovery settings as a substance that passes standard THC screening. Gabapentin is increasingly used by residents as a mood-altering substance that evades standard screening. The 15 panel card covers all four alongside a complete opioid and stimulant baseline for $0.97 per card — the most cost-effective comprehensive specialty-panel screening option available. |
| Drug Courts and Probation | Court-ordered comprehensive substance monitoring covering Gabapentin as a legal substance workaround, K2 as a legal synthetic cannabinoid alternative, alcohol abstinence monitoring via EtG, fentanyl supply contamination detection, full stimulant and opioid baseline | Court-supervised individuals have documented patterns of using legal substance workarounds that pass standard drug screens. Gabapentin and K2 are two of the most commonly documented. Per NADCP best practice standards, comprehensive monitoring including emerging substances is recommended for court supervision programs. The 15 panel card covers both legal-substance workarounds simultaneously alongside EtG, FEN, and the full professional baseline at $0.97 per card. |
K2 Drug Testing in Correctional Facilities: Why Standard THC Panels Miss It and How the 15 Panel Dip Card Closes That Gap
K2 (synthetic marijuana, Spice) has been documented as among the most significant contraband substances in US correctional institutions for over a decade. The substances are chemically diverse — new K2 compounds are continuously synthesized to stay ahead of existing detection methods — but share a common characteristic: none of them produce a positive result on any THC immunoassay panel at any cutoff level because synthetic cannabinoid compounds are structurally distinct from delta-9-THC. A correctional officer holding a 28-panel cup result showing negative THC cannot determine from that result alone whether the individual used K2 within the testing window.
The 15 panel dip card's dedicated K2 panel at 50 ng/mL uses a first-generation synthetic cannabinoid antibody that provides detection capability independent of the THC panel. This panel is calibrated to the JWH-018 metabolite and related synthetic cannabinoid compounds that remain the most prevalent K2 variants in institutional drug supply. Per NIDA data, K2/Spice is documented in correctional settings partly because it was legal to purchase and could be introduced through mailed packages. The 15 panel card provides K2 detection alongside GABA, EtG, FEN, and the complete professional baseline in a single $0.97 per card bulk format with same-day shipping from 12 Panel Now.
15 Panel vs 12 Panel Dip Card: The Four Panels That Change and the Specific Programs That Need the Upgrade
The upgrade from a standard 12 panel dip card to the 15 panel dip card replaces THC with four specialty panels: GABA at 1000 ng/mL, EtG at 300 ng/mL, FEN at 20 ng/mL, and K2 at 50 ng/mL. This is a fundamental substance profile shift: the 15 panel card is not a 12 panel card with extra panels added, it is a differently configured card that prioritizes four emerging substance detection capabilities over cannabis screening.
Programs should select the 15 panel card over the 12 panel card when: (1) Gabapentin misuse is documented in their screening population or required by protocol, (2) alcohol abstinence monitoring over the inter-test interval is a program requirement, (3) fentanyl detection is required per the July 2025 SAMHSA federal mandate or program policy, and (4) K2 synthetic cannabinoid detection is a documented need. Programs that require cannabis (THC) detection alongside these four specialty substances should consider the 16 panel dip card range, which includes THC alongside EtG, FEN, and Kratom in a 16-substance format. Programs that need only EtG and FEN without Gabapentin or K2 should consider the 14 panel EtG/FEN card at $1.39, which retains THC, PCP, BAR, and the full classical professional baseline. Contact 12 Panel Now at 561-897-9238 to discuss which configuration is right for your program's specific substance monitoring requirements.
What Does “Forensic Use Only” Mean for 15 Panel Dip Cards?
- 1. What It Means
A “Forensic Use Only” label indicates that the 10 panel dip card:
Has not undergone FDA 510(k) clearance as a medical diagnostic device
Is intended for screening and compliance monitoring purposes only
Is designed for use in controlled environments such as workplace, legal, or institutional testing programs
15 Panel Dip Card frequently asked questions
A 15 Panel Dip Card provides broader substance screening, helping organizations monitor a wider range of drugs and emerging substances within a single test.
Yes. Many employers, treatment centers, and correctional facilities use multi-panel tests to efficiently screen large numbers of individuals.
Yes. By combining multiple drug panels into one device, testing programs can simplify collection procedures and improve workflow efficiency.
Results should be interpreted within the manufacturer's recommended reading window to ensure accuracy and reliability.
Yes. It is commonly used in workplace programs, treatment facilities, correctional settings, and other compliance-monitoring environments.
It screens for additional substances beyond traditional testing panels, providing a more complete view of potential substance use.
Yes. Many organizations use it for ongoing testing schedules where consistent screening is required.
Do not use the device. Replace it with a new, unopened test to ensure valid results.
Yes. Confirmatory laboratory testing is generally recommended before making important employment, legal, or disciplinary decisions.
Following standardized collection procedures and staff training guidelines helps ensure reliable and consistent testing practices.
Yes. Multi-panel drug testing is often used as part of broader workplace safety and compliance initiatives.
Organizations should consider the substances they need to monitor, testing frequency, budget, and program requirements.
Yes. Expanded-panel testing can help organizations monitor substances that may not be included in basic screening programs.
Store them according to the manufacturer's recommendations in a clean, dry environment away from excessive heat or moisture.
Yes. It can be used as part of policies designed to promote workplace safety and compliance.
On-site testing provides faster results, reduces administrative delays, and allows immediate screening when needed.
Many suppliers offer wholesale, OEM, or private-label options for organizations with specialized requirements.
Regular reviews help ensure the chosen test continues to match current program goals and substance-monitoring needs.
Yes. Recovery and accountability programs often use expanded-panel tests to support ongoing monitoring efforts.
Compare panel composition, accuracy, ease of use, result turnaround time, pricing, and supplier support before making a purchasing decision.
